The progress of humane experimental technique

Alternatives to Laboratory Animals

Volumn 27, Issue 6, 1999, Pages 915-922

  Russell, William M S ^a  

^a UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL WELFARE; CONFERENCE PAPER; EXPERIMENTAL ANIMAL; GENETIC ENGINEERING; MEDICAL RESEARCH; PRIORITY JOURNAL; TRANSGENIC ANIMAL;

ANIMALIA;

EID: 0033390323     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119299902700605     Document Type: Conference Paper

References (47)

1. Worden, A.N. & Lane-Petter, W., eds (1957). The UFAW Handbook on the Care and Management of Laboratory Animals, 2nd edn, 951pp. London, UK: UFAW.
2. Russell, W.M.S. & Burch, R.L. (1959). The Principles of Humane Experimental Technique, 238pp. London, UK: Methuen.
3. Cervinka, M. (1995). Alternatives in research and testing at the Department of Biology, Charles University Medical Faculty, Hradec Králové. In Alternatives to Animal Experimentation (ed. M. Cervinka & M. Balls), pp. 65-66. Hradec Králové, Czech Republic: Nucleus HK for Tempus JEP 1485.
4. Hofstadter, D. (1980). Gödel, Escher, Bach: An Eternal Golden Braid, 777pp. Harmondsworth, UK: Penguin Books.
5. Balls, M. & Fentem, J.H. (1994). The Fund for the Replacement of Animals in Medical Experiments (FRAME): 23 years of campaigning for the Three Rs. In Alternatives to Animal Testing (ed. C.A. Reinhardt), pp. 45-55. Weinheim, Germany: VCH Publishers.
6. Balls, M. (1995). Acceptance of the Three Rs concept: a battle won. ATLA 23, 1-3.
7. Russell, W.M.S. & Burch, R.L. (1995). Prefatory note. ATLA 23, 11-13.
8. Hegarty, T. (1995). Dorothy Hegarty and the founding of FRAME: a personal recollection. ATLA 23, 15-17.
9. Annett, B. (1995). The Fund for the Replacement of Animals in Medical Experiments (FRAME): the first 25 years. ATLA 23, 19-32.
10. Balls, M. (1995). On keeping your eyes on the prize: Dorothy Hegarty and acceptance of the concept of replacement of laboratory animal procedures in research, education and testing. ATLA 23, 756-774.
11. Ungar, K. (1997). A bibliometric evaluation of the performance of ATLA. ATLA 25, 67-69.
12. Goldberg, A.M., van Zutphen, L.F.M. & Principe, M.L., eds (1995). The World Congress on Alternatives and Animal Use in the Life Sciences, 738pp. New York, USA: Mary Ann Liebert.
13. Van Zutphen, L.F.M. & Balls, M., eds (1997). Animal Alternatives, Welfare and Ethics, 1260pp. Amsterdam, The Netherlands: Elsevier.
14. Anon. (1999). 3rd World Congress on Alternatives and Animal Use in the Life Sciences. ATLA 27, 227-228.
15. Lane-Petter, W. (1961). Provision of Laboratory Animals for Research: a Practical Guide, 147pp. Amsterdam, The Netherlands: Elsevier.
16. Burch, R.L. (1995). The progress of humane experimental technique since 1959: a personal view. ATLA 23, 776-783.
17. Libowitz, L.A. (1998). Letter from CAAT. ATLA 26, 577.
18. Niemi, S.M. & Willson, J.E., eds (1993). Refinement and Reduction in Animal Testing, 138pp. Bethesda, MD, USA: SCAW.
19. Venable, J.S. (1997). Preface. The WARDS Journal of Refinement Recognition 1, 1-2.
20. Festing, M.F.W. (1998). The FRAME reduction initiative. ATLA 26, 377-378.
21. Kozlowski, R. (1998). Chemical wizardry. Oxford Today 10 (No. 3), 22-23.
22. Russell, W.M.S. (1995). Speech at the awards luncheon. In The World Congress on Alternatives and Animal Use in the Life Sciences (ed. A.M. Goldberg, L.F.M. Van Zutphen & M.L. Principe), pp. 71-80. New York, USA: Mary Ann Liebert.
23. Borchardt, R.T., Smith, P.L. & Wilson, G., eds (1996). Models for Assessing Drug Absorption and Metabolism, 444pp. New York, USA. Plenum Press.
24. Russell, W.M.S. (1997). A festival of animals. In Animal Alternatives, Welfare and Ethics (ed. L.F.M. Van Zutphen & M. Balls), pp. 9-20. Amsterdam, The Netherlands: Elsevier.
25. Hendriksen, C.F.M. & de Leeuw, W.A. (1998). Discussion. Research in Immunology 149, 611-620.
26. Hendriksen, C.F.M. & de Leeuw, W.A. (1998). Production of monoclonal antibodies by the ascites method in laboratory animals. Research in Immunology 149, 535-542.
27. De Geus, B. & Hendriksen, C.F.M. (1998). Introduction. Research in Immunology 149, 533-534.
28. Hendriksen, C.F.M. (1998). A call for a European prohibition of monoclonal antibody production by the ascites procedure in laboratory animals. ATLA 26, 523-540.
29. Hendriksen, C.F.M. (1988). Laboratory Animals in Vaccine Production and Control: Replacement, Reduction and Refinement (transl. H. Volman), 158pp. Dordrecht, The Netherlands: Kluwer Academic Publishers.
30. van der Kamp, M.D.O. (1994). Ways of Replacing, Reducing or Refining the Use of Animals in the Quality Control of Veterinary Vaccines, 107pp. Lelystad, The Netherlands: Institute for Animal Science and Health.
31. Harrison, P.F. & Rosenfield, A., eds (1996). Contraceptive Research and Development, 519pp. Washington, DC, USA: National Academy Press.
32. Weisser, K. & Hechler, U. (1997). Animal Welfare Aspects in the Quality Control of Immunobiologicals: a Critical Evaluation of the Animal Tests in Pharmacopoeial Monographs (transl. M. Halder), 348pp. Nottingham, UK: FRAME.
33. Schnädelbach, D. (1997). Foreword. In Animal Welfare Aspects in the Quality Control of Immunobiologicals: A Critical Evaluation of the Animal Tests in Pharmacopoeial Monographs (ed. K. Weisser & U. Hechler; transl. M. Halder), p.1. Nottingham, UK: FRAME.
34. Liu, M.A., Hilleman, M.R. & Kurth, R., eds (1995). DNA Vaccines: A New Era in Vaccinology, 294pp. New York, USA: New York Academy of Sciences.
35. Langley, G. (1998). Biopharmaceuticals: from animals or plants? ATLA 26, 569-570.
36. Notarianni, E. & Evans, M.J. (1992). Transgenesis and genetic engineering in domestic animals. In Transgenesis: Application of Gene Transfer (ed. J.A.H. Murray), pp. 251-281. Chichester, UK: John Wiley.
37. van Zutphen, L.F.M. & van der Meer, M., eds (1997). Welfare Aspects of Transgenic Animals, 119pp. Berlin, Germany: Springer-Verlag.
38. Hendriksen, C.F.M. & Morton, D.B., eds (1999). Humane Endpoints in Animal Experiments for Biomedical Research, 150pp. London, UK: RSM Press.
39. Wolf, E. & Wanke, R. (1997). Growth hormone overproduction in transgenic mice: phenotypic alterations and deduced animal models. In Welfare Aspects of Transgenic Animals (ed. L.F.M. van Zutphen & M. van der Meer), pp. 26-47. Berlin, Germany: Springer-Verlag.
40. Flecknell, P.A. (1997). Refinement of rodent and rabbit anaesthesia and analgesia. The WARDS Journal of Refinement Recognition 1, 7-17.
41. Wilson, S.P., Yeomans, D.C., Bender, M.A., Lu, Y., Goins, W.F. & Glorioso, J.C. (1999). Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proceedings of the National Academy of Sciences, USA 96, 3211-3216.
42. Hume, C.W. (1957). The strategy and tactics of experimentation. Lancet 23 November 1957, 1049-1052.
43. Pioda, L. (1994). The position of the authorities. In Alternatives to Animal Testing (ed. C.A. Reinhardt), pp. 173-176. Weinheim, Germany: VCH Publishers.
44. Anon. (1999). OECD accepts up-and-down procedure. ATLA 27, 220.
45. Anon. (1999). Many steps too far: proposed increases in laboratory animal use. FRAME News 47, 1-2.
46. Balls, M. (1999). The precautionary principle should be used with caution - and should be applied to animal experimentation and genetic manipulation, not merely to protection of the environment. ATLA 27, 1-5.
47. Libowitz, L.A. (1999). Letter from CAAT. ATLA 27, 37.